Sign inGet started

HARPER PHILIP R

Insider CIK 1181073 · GNMX 10% owner · ACAS Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
GNMC Aevi Genomic Medicine, Inc P Buy2017-09-012017-09-0683,775$1.20 $100.5K4,959,819SEC↗
GNMX Aevi Genomic Medicine, Inc P Buy2017-08-232017-08-245,700$1.20 $6.8K4,876,044SEC↗
GNMX Aevi Genomic Medicine, Inc P Buy2017-08-222017-08-244,661$1.20 $5.6K4,870,344SEC↗
GNMX Aevi Genomic Medicine, Inc P Buy2017-08-102017-08-1420,470$1.19 $24.4K4,865,683SEC↗
GNMX Aevi Genomic Medicine, Inc P Buy2017-03-242017-03-2753,826$1.60 $86.1K4,845,213SEC↗
GNMX Aevi Genomic Medicine, Inc P Buy2017-03-232017-03-274,705$1.60 $7.5K4,791,387SEC↗
GNMX Aevi Genomic Medicine, Inc P Buy2017-03-222017-03-271,000,000$1.79 $1.79M4,786,682SEC↗
ACAS AMERICAN CAPITAL, LTD D To issuer deriv2017-01-032017-01-04156,250— $00SEC↗
ACAS AMERICAN CAPITAL, LTD D To issuer deriv2017-01-032017-01-0493,750— $00SEC↗
ACAS AMERICAN CAPITAL, LTD D To issuer deriv2017-01-032017-01-0493,750— $00SEC↗
ACAS AMERICAN CAPITAL, LTD D To issuer2017-01-032017-01-04930,762— $00SEC↗
ACAS AMERICAN CAPITAL, LTD D To issuer2017-01-032017-01-0412,747— $00SEC↗
ACAS AMERICAN CAPITAL, LTD S Sale2015-12-032015-12-0470,000$15.31 $1.07M930,762SEC↗
ACAS AMERICAN CAPITAL, LTD S Sale2015-03-122015-03-1339,391$14.65 $577.1K1,000,762SEC↗
ACAS AMERICAN CAPITAL, LTD S Sale2014-12-112014-12-1543,600$14.72 $641.8K1,040,153SEC↗
ACAS AMERICAN CAPITAL, LTD S Sale2014-03-072014-03-10120,000$15.51 $1.86M1,083,753SEC↗
ACAS AMERICAN CAPITAL, LTD S Sale2014-02-252014-02-2560,000$15.25 $915.0K1,203,753SEC↗
ACAS AMERICAN CAPITAL, LTD S Sale2014-02-202014-02-21120,000$15.63 $1.88M1,263,753SEC↗
ACAS AMERICAN CAPITAL, LTD S Sale2013-12-122013-12-1615,000$14.76 $221.4K1,383,753SEC↗